These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 29340614)

  • 1. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.
    Paul KC; Schulz J; Bronstein JM; Lill CM; Ritz BR
    JAMA Neurol; 2018 Mar; 75(3):360-366. PubMed ID: 29340614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression in the LRRK2-Asssociated Parkinson Disease Population.
    Saunders-Pullman R; Mirelman A; Alcalay RN; Wang C; Ortega RA; Raymond D; Mejia-Santana H; Orbe-Reilly M; Johannes BA; Thaler A; Ozelius L; Orr-Urtreger A; Marder KS; Giladi N; Bressman SB;
    JAMA Neurol; 2018 Mar; 75(3):312-319. PubMed ID: 29309488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.
    Davis MY; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Goldman JG; Stebbins GT; Bernard B; Wszolek ZK; Ross OA; Dickson DW; Eidelberg D; Mattis PJ; Niethammer M; Yearout D; Hu SC; Cholerton BA; Smith M; Mata IF; Montine TJ; Edwards KL; Zabetian CP
    JAMA Neurol; 2016 Oct; 73(10):1217-1224. PubMed ID: 27571329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cumulative genetic risk score predicts progression in Parkinson's disease.
    Pihlstrøm L; Morset KR; Grimstad E; Vitelli V; Toft M
    Mov Disord; 2016 Apr; 31(4):487-90. PubMed ID: 26853697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic determinants of motor and cognitive outcomes in Parkinson's disease.
    Chung SJ; Armasu SM; Biernacka JM; Anderson KJ; Lesnick TG; Rider DN; Cunningham JM; Eric Ahlskog J; Frigerio R; Maraganore DM
    Parkinsonism Relat Disord; 2012 Aug; 18(7):881-6. PubMed ID: 22658654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
    Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
    Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Pagano G; De Micco R; Yousaf T; Wilson H; Chandra A; Politis M
    Neurology; 2018 Sep; 91(10):e894-e905. PubMed ID: 30089615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.
    Lee PC; Artaud F; Cormier-Dequaire F; Rascol O; Durif F; Derkinderen P; Marques AR; Bourdain F; Brandel JP; Pico F; Lacomblez L; Bonnet C; Brefel-Courbon C; Ory-Magne F; Grabli D; Klebe S; Mangone G; You H; Mesnage V; Brice A; Vidailhet M; Corvol JC; Elbaz A;
    Mov Disord; 2019 Nov; 34(11):1663-1671. PubMed ID: 31518456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between lifestyle factors and Parkinson's disease progression and mortality.
    Paul KC; Chuang YH; Shih IF; Keener A; Bordelon Y; Bronstein JM; Ritz B
    Mov Disord; 2019 Jan; 34(1):58-66. PubMed ID: 30653734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GWAS Identifies DPP6 as Risk Gene of Cognitive Decline in Parkinson's Disease.
    Li C; Hou Y; Ou R; Wei Q; Zhang L; Liu K; Lin J; Chen X; Song W; Zhao B; Wu Y; Shang H
    J Gerontol A Biol Sci Med Sci; 2024 Aug; 79(8):. PubMed ID: 38875006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polygenic risk score with response to deep brain stimulation in Parkinson's disease.
    Yoon E; Ahmed S; Li R; Bandres-Ciga S; Blauwendraat C; Dustin I; Scholz S; Hallett M; Ehrlich D
    BMC Neurol; 2023 Apr; 23(1):143. PubMed ID: 37016359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson's Disease.
    Chuang YH; Lu AT; Paul KC; Folle AD; Bronstein JM; Bordelon Y; Horvath S; Ritz B
    J Parkinsons Dis; 2019; 9(2):389-400. PubMed ID: 30958317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.
    Keener AM; Paul KC; Folle A; Bronstein JM; Ritz B
    J Parkinsons Dis; 2018; 8(2):353-362. PubMed ID: 29843251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function.
    Ng A; Chander RJ; Tan LC; Kandiah N
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1056-60. PubMed ID: 26117438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Parkinson disease risk loci with mild parkinsonian signs in older persons.
    Shulman JM; Yu L; Buchman AS; Evans DA; Schneider JA; Bennett DA; De Jager PL
    JAMA Neurol; 2014 Apr; 71(4):429-35. PubMed ID: 24514572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organophosphate pesticides and PON1 L55M in Parkinson's disease progression.
    Paul KC; Sinsheimer JS; Cockburn M; Bronstein JM; Bordelon Y; Ritz B
    Environ Int; 2017 Oct; 107():75-81. PubMed ID: 28689109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.
    Foo JN; Chew EGY; Chung SJ; Peng R; Blauwendraat C; Nalls MA; Mok KY; Satake W; Toda T; Chao Y; Tan LCS; Tandiono M; Lian MM; Ng EY; Prakash KM; Au WL; Meah WY; Mok SQ; Annuar AA; Chan AYY; Chen L; Chen Y; Jeon BS; Jiang L; Lim JL; Lin JJ; Liu C; Mao C; Mok V; Pei Z; Shang HF; Shi CH; Song K; Tan AH; Wu YR; Xu YM; Xu R; Yan Y; Yang J; Zhang B; Koh WP; Lim SY; Khor CC; Liu J; Tan EK
    JAMA Neurol; 2020 Jun; 77(6):746-754. PubMed ID: 32310270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.
    Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB
    JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic influences on cognitive decline in Parkinson's disease.
    Morley JF; Xie SX; Hurtig HI; Stern MB; Colcher A; Horn S; Dahodwala N; Duda JE; Weintraub D; Chen-Plotkin AS; Van Deerlin V; Falcone D; Siderowf A
    Mov Disord; 2012 Apr; 27(4):512-8. PubMed ID: 22344634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.